Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Howdens hails 'encouraging' start to year as Q1 revenues rise

(Sharecast News) - Trade kitchen and joinery supplier Howden Joinery reported a rise in first-quarter depot revenue on Tuesday as it hailed an "encouraging" start to the year. In the 16 weeks to 14 April, UK depot revenue rose 5.4% on the same period a year earlier and 4% on a same depot basis.

Howdens said that as a result of the additional 53rd week in 2023, there was an earlier start to FY2024 with depots trading in the first week of the current year when they were closed in the prior year. This 'phasing' impact corrects itself at the end of FY2024. Adjusting for this, UK depot revenue was up 1.9% on the prior year and 0.5% on a same depot basis.

In international depots, which make up around 3% of group revenue, there was a 4.6% increase on the same period a year earlier but a 0.1% fall on a same depot basis. Adjusting for the phasing impact mentioned above, this was a 2.2% increase and a 2.5% decline on a same depot basis.

Howdens said that at the start of the new financial year, it has implemented modest price increases across all geographies. These are being retained at "acceptable" levels as it looks to maintain the right balance between margin and volume.

Chief executive Andrew Livingston said: "We have made an encouraging start to the year with trading in line with our expectations. We are also continuing to make good progress in implementing our strategic initiatives which drive profitable growth.

"We are on track with the outlook for 2024, while mindful of the second half weighting of sales from our Autumn peak trading period."

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.